Frontier Nuclear and Minerals Inc. reported unaudited financial results for the six months ended December 31, 2025, showing a net loss of $14,954,249 CAD compared to $2,357,257 CAD in the prior year period. The company recorded negative operating cash flow of $4,443,988 CAD and an accumulated deficit of $57,488,275 CAD as of December 31, 2025. During the period, Frontier raised gross proceeds of US$36,248,727 through its ATM sales agreement and completed the acquisition of Global Uranium and Enrichment Limited in February 2026 to consolidate U.S. uranium assets. The company also invested in Kadmos Energy Services for SMR technology and American Uranium Limited. Frontier Nuclear and Minerals Inc. operates as a nuclear fuel cycle and critical minerals exploration company focused on uranium projects in the United States, Canada, and Namibia.

Frontier Nuclear and Minerals Inc. appointed Joshua Girnun and Donal Carroll to its Board of Directors on July 20, 2026. The company also reconstituted its Audit, Nominating and Corporate Governance, and Compensation committees. Donal Carroll, current CFO of Quantum BioPharma Ltd., was appointed Chair of the Audit Committee. Joshua Girnun, Co-Founder of Ridge Metals Group, joined as an Audit Committee member. The company's upcoming annual general meeting is scheduled for August 25, 2026. Frontier Nuclear and Minerals Inc. is a nuclear fuel cycle company focused on uranium exploration and development.

Frontier Nuclear and Minerals Inc. announced the launch of a major 2026 drilling program at its Pine Ridge Uranium Project on July 14, 2026. The company operates in the mining industry, focusing on the exploration and development of uranium and mineral resources.